The drug, tirzepatide, is sold under the brand name Mounjaro and affects feelings of hunger and fullness, as well as changing ...

The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

A woman who takes weight loss medication has called Health Secretary Wes Streeting “naive” after he suggested weight-loss ...

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia.Authors Paul Joyce ...

This article delves into the pros and cons of these drugs, addressing potential side effects (including the rare ones).

Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven major gains in recent times. And that's the company's weight loss drugs.

The new trial aims to gather evidence of the effects of the drug tirzepatide – sold by pharmaceutical company Lily under brand name Mounjaro ...

A woman from Burnham has called the government 'naïve' for suggesting weight-loss jabs would help unemployed people return to the workplace.

IN a world with soaring obesity rates, fat jabs have arrived and taken the world of the rich and beautiful by storm. The injections have allegedly helped celebrities like Elon Musk, Sharon ...